| Literature DB >> 15465539 |
Matt Feinsod1, Wiley A Chambers.
Abstract
Conducting clinical trials in a regulated environment constitutes unfamiliar territory for most physicians. There exists no formal training in this subject, so many clinicians lack even a basic understanding of the procedures required by the Federal Food, Drug, and Cosmetic Act and their implications vis-à-vis clinical practice. The authors distill drug regulation to relevant applications and elucidate the rationale and procedures for submitting an Investigational New Drug application by providing a user-friendly road map of the process.Mesh:
Substances:
Year: 2004 PMID: 15465539 DOI: 10.1016/j.ophtha.2004.05.022
Source DB: PubMed Journal: Ophthalmology ISSN: 0161-6420 Impact factor: 12.079